Efficacy of acupuncture in the prevention and treatment of chemotherapy-induced nausea and vomiting in patients with advanced cancer: a multi-center, single-blind, randomized, sham-controlled clinical research

[1] Navari RM(2016)Antiemetic prophylaxis for chemotherapy-induced nausea and vomiting New Engl J Med. 374 1356-1367

[2] Aapro M(2017)Antiemetics: American society of clinical oncology clinical practice guideline update J Clin Oncol 35 3240-3261

[3] Hesketh PJ(2020)Olanzapine 5 mg plus standard antiemetic therapy for the prevention of chemotherapy-induced nausea and vomiting (J-FORCE): a multicentre, randomized, double-blind, placebo-controlled, phase 3 trial Lancet Oncol. 21 242-249

[4] Kris MG(2012)Prevention of delayed nausea: a University of Rochester Cancer Center community clinical oncology program study of patients receiving chemotherapy J Clin Oncol 30 3389-3395

[5] Basch E(2018)Chemotherapy-induced nausea and vomiting (CINV) and adherence to antiemetic guidelines: results of a survey of oncology nurses Support Care Cancer. 26 557-564

[6] Bohlke K(2009)Obstacles to the implementation of antiemetic guidelines J Natl Compr Cancer Net. 7 601-605

[7] Barbour SY(2012)Communicating about chemotherapy-induced nausea and vomiting: a comparison of patient and provider perspectives J Nat Compr Cancer Net. 10 149-157

[8] Clark-Snow RA(2015)Chemotherapy-induced nausea and vomiting: time for more emphasis on nausea? Oncologist. 20 576-583

[9] Hashimoto H(2018)Evolving role of neurokinin 1-receptor antagonists for chemotherapy-induced nausea and vomiting Onco Targets Ther. 11 6459-6478

[10] Abe M(2018)Integrative therapies during and after breast cancer treatment: ASCO endorsement of the SIO clinical practice guideline J Clin Oncol 36 2647-2655

[1] Navari RM(2016)Antiemetic prophylaxis for chemotherapy-induced nausea and vomiting New Engl J Med. 374 1356-1367

[2] Aapro M(2017)Antiemetics: American society of clinical oncology clinical practice guideline update J Clin Oncol 35 3240-3261

[3] Hesketh PJ(2020)Olanzapine 5 mg plus standard antiemetic therapy for the prevention of chemotherapy-induced nausea and vomiting (J-FORCE): a multicentre, randomized, double-blind, placebo-controlled, phase 3 trial Lancet Oncol. 21 242-249

[4] Kris MG(2012)Prevention of delayed nausea: a University of Rochester Cancer Center community clinical oncology program study of patients receiving chemotherapy J Clin Oncol 30 3389-3395

[5] Basch E(2018)Chemotherapy-induced nausea and vomiting (CINV) and adherence to antiemetic guidelines: results of a survey of oncology nurses Support Care Cancer. 26 557-564

[6] Bohlke K(2009)Obstacles to the implementation of antiemetic guidelines J Natl Compr Cancer Net. 7 601-605

[7] Barbour SY(2012)Communicating about chemotherapy-induced nausea and vomiting: a comparison of patient and provider perspectives J Nat Compr Cancer Net. 10 149-157

[8] Clark-Snow RA(2015)Chemotherapy-induced nausea and vomiting: time for more emphasis on nausea? Oncologist. 20 576-583

[9] Hashimoto H(2018)Evolving role of neurokinin 1-receptor antagonists for chemotherapy-induced nausea and vomiting Onco Targets Ther. 11 6459-6478

[10] Abe M(2018)Integrative therapies during and after breast cancer treatment: ASCO endorsement of the SIO clinical practice guideline J Clin Oncol 36 2647-2655